The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.

Recruiting N/A Interventional Study
Heart Failure Heart Failure With Reduced Ejection Fraction Obesity Overweight
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
110 (estimated)
Sponsor
University of Oxford · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study looks at the effects of weight loss in people who have heart failure with reduced ejection fraction (HFpEF) and are overweight or obese. The main questions it aims to answer are whether weight loss in this group of people improves: * The heart's shape and how well it pumps blood * The person's quality of life and how much they can exercise Participants will attend 2 study visits, sep…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Heart failure determined by left ventricular ejection fraction 20-45% * Body mass index \> 27.5kg/m\^2 Exclusion Criteria: * Contraindications to magnetic resonance imaging * NYHA class IV * Pregnancy, planned pregnancy or lactating * Significant valvular, ischemic, infiltra…
Contacts

Jenny Rayner, DPhil

+441865221172

jenny.rayner@cardiov.ox.ac.uk

CONTACT

Max Fenski, MD

+441865221172

max.fenski@cardiov.ox.ac.uk

CONTACT